CoA Composition
BPC-157: 5.76mgTB-500: 5.65mg
Pre-order item: This product is available to reserve now and is expected to ship between 13 July 2026 and 17 July 2026.
Pentadecapeptide + Thymosin Beta-4 Fragment Research Blend
BPC-157 + TB-500 (10mg) will be supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.
This pre-blended vial — known in the research community as the Wolverine Stack — combines two of the most studied tissue repair compounds via complementary mechanisms.
BPC-157 is a synthetic pentadecapeptide derived from gastric juice protein sequence, studied for inflammatory signalling, cytoprotection, and tissue repair across tendon, ligament, muscle, and GI models. TB-500 is a Thymosin Beta-4 fragment studied for cell migration and angiogenesis. The combination is studied for addressing both inflammatory signalling/cytoprotection and vascular/migration mechanisms simultaneously.
Key Research Areas
Connective Tissue Models — Both compounds studied individually in tendon and ligament repair; combined for multi-mechanism research Muscle Repair — Studied across acute and chronic muscle injury models Joint Repair Research — Studied for inflammatory and tissue repair signalling in joint structures Angiogenesis — TB-500 studied for vascular formation at injury sites Gastrointestinal Models — BPC-157's gastric origin extends utility to gut barrier and GI tissue research
Supplied as lyophilized powder at ≥99% purity, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.
⚠ For in-vitro research and laboratory use only. Not for human consumption.
⚠ For in-vitro research and laboratory use only. Not intended for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.